FMP

FMP

Enter

FBRX - Forte Biosciences, Inc.

Financial Summary of Forte Biosciences, Inc.(FBRX), Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States.

About

ceo

Dr. Paul A. Wagner Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.fortebiorx.com

exchange

NASDAQ

Description

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

CIK

0001419041

ISIN

US34962G1094

CUSIP

34962G109

Address

3060 Pegasus Park Drive

Phone

310 618 6994

Country

US

Employee

9

IPO Date

Apr 13, 2017

Summary

CIK

0001419041

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

34962G109

ISIN

US34962G1094

Country

US

Price

0.7

Beta

1.65

Volume Avg.

35.16k

Market Cap

25.34M

Shares

-

52-Week

0.38-1.29

DCF

0.38

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.7

P/B

-

Website

https://www.fortebiorx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest FBRX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep